EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 3.0

Resveratrol Nanoformulations for Cancer Management: A Comprehensive Review of Disease-Specific Strategies and Clinical Translational Barriers

Huifang Yang iD, Zilin Cheng, Yilin Wang iD, Kexin Tang, Tongtong Zeng, Jing Guo

International Journal of Nanomedicine · 2026

DOI: 10.2147/ijn.s610050 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Nanomedicine, 2026. Verfasst von Huifang Yang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, People's Republic of China. Hauptthemen laut MEDLINE: Resveratrol, Neoplasms, Nanoparticle Drug Delivery System, Stilbenes. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ResveratrolNeoplasmsNanoparticle Drug Delivery SystemStilbenesNanoparticlesHumansAnimalsAntineoplastic AgentsNanomedicine

Stichwörter der Autor:innen

bioavailabilitycancer therapyclinical translationdrug delivery systemsnanoparticlesresveratrol

Substanzen

ResveratrolNanoparticle Drug Delivery SystemStilbenesAntineoplastic Agents

Autor:innen und Institutionen

  • Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, People's Republic of China.

ORCID-Profile: Huifang Yang, Yilin Wang

Zitieren

APA

Yang, H., Cheng, Z., Wang, Y., Tang, K., Zeng, T., & Guo, J. (2026). Resveratrol Nanoformulations for Cancer Management: A Comprehensive Review of Disease-Specific Strategies and Clinical Translational Barriers. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s610050

Vancouver

Yang H, Cheng Z, Wang Y, Tang K, Zeng T, Guo J. Resveratrol Nanoformulations for Cancer Management: A Comprehensive Review of Disease-Specific Strategies and Clinical Translational Barriers. International Journal of Nanomedicine. 2026. doi:10.2147/ijn.s610050

BibTeX
@article{Yang2026,
  author = {Yang, Huifang and Cheng, Zilin and Wang, Yilin and Tang, Kexin and Zeng, Tongtong and Guo, Jing},
  title = {Resveratrol Nanoformulations for Cancer Management: A Comprehensive Review of Disease-Specific Strategies and Clinical Translational Barriers},
  journal = {International Journal of Nanomedicine},
  year = {2026},
  doi = {10.2147/ijn.s610050}
}
Kostenlos starten →